Australia TGA ARTG record

Nasal breathing aid, external

Australia TGA ARTG Registered Device · Actor Pharmaceuticals Pty Ltd · Zhejiang Hongyu Medical Commodity Co Ltd · Class I · Started December 19, 2023

Good Name: Actor Pharmaceuticals Pty Ltd - Nasal breathing aid, external

Device classification

Risk Class: Class I
Product Type: Single Device Product
ARTG Category: General

Registration information

Start Date: December 19, 2023
Effective Date: December 19, 2023

Sponsor

Name: Actor Pharmaceuticals Pty Ltd

Manufacturer

Name: Zhejiang Hongyu Medical Commodity Co Ltd
Country: China
Address: No 668 ChanHua Road, Fotang Town Industrial Functional Area, Yiwu City, Zhejiang Province, 322002

Intended purpose

An external medical device intended to improve breathing by decreasing nasal resistance, thus increasing nasal airflow. The medical device consists of an adhesive bandage with two parallel elastic strips placed on the bridge of the nose. The medical device acts with an upwards pulling force to flare the nostrils and thereby opening the nares. The medical device provides temporary relief from transient causes of breathing difficulties resulting from structural abnormalities and/or nasal congestion. The medical device is single use.

About this record

Access comprehensive regulatory information for Nasal breathing aid, external in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class I is sponsored by Actor Pharmaceuticals Pty Ltd, manufactured by Zhejiang Hongyu Medical Commodity Co Ltd in China. The device registration started on December 19, 2023.

This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.